Pregled bibliografske jedinice broj: 131990
Polymorphism of CYP2C9 and CYP2D6 in Predicting Drug Metabolism Phenotype
Polymorphism of CYP2C9 and CYP2D6 in Predicting Drug Metabolism Phenotype // Abstracts of the ..... ; u: Clinical Chemistry and Laboratory Medicine 40 (2002) (S)
XX, XXX, 2002. str. S 125-S 125 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 131990 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Polymorphism of CYP2C9 and CYP2D6 in Predicting Drug Metabolism Phenotype
Autori
Topić, Elizabeta ; Štefanović, Mario ; Čulav, Jadranka ; Samardžija, Marina ; Blazinić, Franciska ; Begonja, Antonija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the ..... ; u: Clinical Chemistry and Laboratory Medicine 40 (2002) (S)
/ - , 2002, S 125-S 125
Skup
XXX
Mjesto i datum
XX, XXX, 2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
CYP2C9 ; CYP2D6 ; anticoagulant and antipsychotic drugs ; side effect
Sažetak
CYP2C9 and CYP2D6 are highly polymorphic enzymes metabolizing anticoagulant and antipsychotic drugs, respectively. Two CYP2C9 alleles, 2C9*2 and 2C9*3, encode for enzymes with 16%– ; ; 20% and 5% of normal activity, respectively. Six CYP2D6 alleles (*3, *4, *5, *6, *7 and *8) encode for inactive enzymes. The aim was to study frequency of 2C9 and 2D6 alleles in healthy Croatian population and assess the association between CYP2D6 polymorphism and side effect in psychiatric patients (n=87) on therapy more than 3 years. The CYP2C9 alleles were identified by PCR-RFLP and CYP2D6 alleles by multiplex PCR. In controls, the frequency of CYP2C9 *2 and *3 allele was 12.7% and 2.9%, respectively, somewhat lower than in Caucasians. Genotype distribution showed 27.5% as heterozygous with one, and 2.0% as heterozygous with two mutations. The results on 2D6 indicated a significant allele (p=0.015, odds=2.542), genotype (p=0.016) and phenotype (p=0.025, odds=5.020) difference between controls and psychiatric patients. Considerably higher frequency of heterozygous (34.2%) and homozygous (13.2%) 2D6*4 allele was found in patients with (n=39) and without (n=48) side effect. The odds ratio of 2.626 for 2D6*4 and of 5.333 for 2D6*6 alleles suggested their significant association with side effect in patients on long-term therapy.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
0134019
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Marina Samardžija
(autor)
Mario Štefanović
(autor)
Franciska Blazinić
(autor)
Antonija Jurak Begonja
(autor)
Jadranka Čulav-Sumić
(autor)
Elizabeta Topić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI